SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (9776)12/17/2003 11:10:19 AM
From: A.J. Mullen  Read Replies (1) | Respond to of 52153
 
Very thought provoking. Worrying that ensuring that trials can occur may depend on denying access to patients who won't or can't sign up.

On placebos, many of these drugs have nasty side-effects. Surely patients without side-effects are likely to deduce that they are part of the control group. I think I remember reading that AIDS patients had been enrolling through more than one doctor after figuring out they were controls.

Ashley